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Obsessive–compulsive disorder (OCD) is characterized by the presence of distressing, 
recurrent and intrusive thoughts, impulses, or doubts as well as behavioral or mental 
rituals. OCD has various subtypes, including the fear of contamination in which indi-
viduals fear bacteria, germs, disease, or bodily secretions, and engage in clinically 
significant cleaning and avoidance rituals. Cognitive–behavioral therapy (CBT) is an 
effective treatment for OCD and involves, among other therapeutic strategies, exposing 
patients to feared stimuli while preventing them to engage in compulsive behaviors. 
In recent years, virtual reality (VR) has shown the potential of in virtuo exposure with 
people suffering from anxiety disorders and OCD. The objective of this pilot study is to 
examine the effectiveness of a CBT program where exposure in conducted in virtuo. 
Three adults suffering from OCD with a dominant subtype of contamination were enrolled 
in a single-case design with multiple baselines across participants. The presence and 
intensity of obsessions and compulsions were assessed daily during baselines of 3-, 
4-, or 5-week, and a 12-session treatment. Follow-up information was gathered after 4 
and 8 months. Treatment outcome is assessed with visual inspection of the graphs and 
ARMA time-series analyses. Clinical information, self-reports, and details of the treat-
ment are provided for each patient. Statistical analyses for the time-series data revealed 
a statistically significant improvement in all three participants, but global improvement is 
considered positive for only two. This study innovates in proving preliminary support for 
the usefulness of VR in the CBT of OCD with contamination features.
Keywords: virtual reality, obsessive–compulsive disorder, cBT, response prevention, exposure
inTrODUcTiOn
Obsessive–compulsive disorder (OCD) is a severe and debilitating mental disorder characterized 
by recurrent and intrusive thoughts, impulses, or doubts that cause marked anxiety in individual, 
as well as behavioral or mental rituals that are performed in order to reduce distress caused by the 
obsessions. Ninety percent of the general population shares similar concerns as people diagnosed 
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with OCD (1). The difference between the two populations is the 
importance given to the presence of thoughts; people with OCD 
attribute much more importance to their thoughts and their abil-
ity to control them than the general population. Despite the fact 
that most people suffering from OCD are aware of the irrational 
aspect of their thoughts, they are unable to stop the unwanted 
thoughts from reoccurring. Compulsions or rituals therefore 
develop in an effort to control thoughts and bring temporary 
relief from their anxiety.
In terms of obsessions, fears may be related to contamination, 
doubts, orderliness, religion, morality, aggression, or sexuality. 
When it comes to compulsions, the most common are cleaning/
washing, checking, ordering/symmetry, and accumulating. More 
precisely, people with a fear of contamination are absorbed by 
worries such as fear of microbes, bacteria, diseases, bodily fluids, 
and chemicals. To ease their fears, they feel the urge to wash 
excessively (hands, body, teeth, clothes), clean household items 
or personal property, and avoid situations in which there are risks 
of contamination. OCD symptoms and avoidance behaviors are 
heterogeneous and led to the development of various subtypes 
(2), such as patients predominantly concerned by contamination 
and washing, checking and verifying, or hoarding. Subtyping 
OCD symptoms does not necessarily imply the need to develop 
different theoretical models and treatments for each subtype 
(2, 3), but is very important in terms of clarifying the stimuli that 
will be targeted in psychotherapy.
Various theoretical models explaining the occurrence of 
OCD have been proposed, referring in particular to various 
factors including biological (4, 5), genetic (6), and psychological 
(1, 7–9). In relation to these theoretical models, most researchers 
agree that OCD develops and evolves because of both cognitive 
and behavioral factors. On the one hand, thoughts are interpreted 
as catastrophic. Imminent danger is associated with thoughts 
stemming from dysfunctional associations with threat and 
danger. These associations with perceived threat can be linked 
to an inflated sense of responsibility, over importance given to 
thoughts or the need to control them, overestimation of danger, 
intolerance of uncertainty, perfectionism, or pathological doubt 
(1, 10, 11).
On the other hand, behavioral factors are also present in the 
development of OCD since individuals try to relieve distress by 
accomplishing rituals or avoidance behaviors, which have short-
term effects in reducing suffering. By resorting to compulsions, 
people with OCD fall into an avoidance trap; that is, avoidance 
behaviors prevent the possibility of confronting fears in order 
to learn that there is no danger and that they can cope with the 
stimuli and tolerate discomfort. In other words, by avoiding at all 
costs to confront or to tolerate feared situations without resorting 
to compulsions, individuals remain convinced that their compul-
sions prevent feared consequences. Fear can thereafter extend 
and generalize to other objects or situations, leading to further 
compulsions.
Cognitive–behavioral therapy (CBT) is an effective treatment 
for OCD, especially due to its technique of exposure and response 
prevention (12, 13). This treatment involves several components 
(e.g., case formulation, psychoeducation, cognitive restructur-
ing, and relapse prevention), including repeated and prolonged 
exposure to stimuli and situations causing distress. Exposure 
usually takes place gradually, in collaboration with the patient 
who is invited to confront moderate fears at the beginning and 
progressively move on to fears triggering higher levels of anxiety. 
During or after exposures, the participant is asked to refrain from 
performing rituals by tolerating anxiety, despite the strong urge 
to resort to compulsions. Up until now, exposure and response 
prevention have been conducted mostly in reality (in  vivo) or 
in imagination. For example, people suffering from OCD with 
contamination subtype are exposed to contaminated stimuli (i.e., 
going into a public restroom) and then asked to tolerate anxiety 
without resorting to washing rituals. However, research suggests 
that traditional exposure may have some limitations (i.e., par-
ticipants may find it difficult to imagine situations and therapists 
may struggle in gaging the intensity of the anxiety-provoking 
stimuli). Despite evidence demonstrating its effectiveness in the 
treatment of OCD, some clinicians are reluctant to use in vivo 
exposure because they feel less knowledgeable or lack training 
as well as equipment for its application (14). Finally, participants 
often express strong apprehension about conducting exposure in 
a real situation (15).
Using virtual reality (VR) in therapy is a new approach that has 
been introduced in order to address some inherent limitations of 
traditional exposure techniques involved in the treatment of anxi-
ety disorders. VR is defined as an application that allows users to 
navigate and interact in real time with a three-dimensional envi-
ronment generated by computers (16) and can be used to conduct 
exposure and response prevention. In virtuo exposure allows user 
to be exposed to anxiety-provoking stimuli (while following the 
same principles as in  vivo exposure), but relies on computer-
generated situations. Recent studies have demonstrated the 
effectiveness of VR in the treatment of various anxiety disorders 
(13, 17–21). VR offers several advantages for exposure (21), such 
as easy access to stimuli, increased control over exposure stimuli, 
reassuring and flexible context of exposure, bypassing problems 
associated with mental imagery, and make exposure more entic-
ing to for patients.
Only a few studies have been published on VR and OCD, these 
having focused on the checking and verification subtype [for a 
review, see Ref. (22)]. Results showed that people suffering from 
OCD reported significantly higher anxiety levels compared with 
the control group (23), which suggest that VR can be used as a 
tool for inducing anxiety in this clinical population and conse-
quently supports its usefulness as a medium for exposure as part 
of CBT. VR can also be used a behavioral measure of verification 
with OCD patients (24).
To the best of our knowledge, there is no treatment study 
focusing on the contribution of VR in CBT for OCD with the 
contamination subtype. Laforest and Bouchard (25) (in revision) 
validated the potential of immersions in VR for conducting 
in  virtuo exposure with participants suffering from OCD with 
a predominant subtype of contamination. They compared 
subjective and physiological reactions of a control group of 20 
non-OCD adults to a group of 12 adults suffering from OCD 
with contamination subtype when immersed in a “neutral” VR 
environment and a “contaminated” public toilet. Results showed 
that people suffering from OCD reported a significantly higher 
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level of anxiety during the immersion in the contaminated virtual 
environment when compared with the control group on both 
state anxiety and heart rate. Having shown the effectiveness of 
VR to elicit anxiety when confronted with stimuli relevant for the 
treatment of OCD, the next step is to evaluate its potential as a 
tool used to conduct in virtuo exposure and response prevention.
The main objective of the current study was to examine the 
efficacy of a therapeutic treatment using VR for the contamina-
tion subtype of OCD. Four variables were examined: (a) the 
presence of obsessions, (b) the presence of compulsions, (c) the 
intensity of obsessions, and (d) the intensity of compulsions. The 
hypotheses were that presence and intensity of obsessions and 
compulsions would decrease following the introduction of CBT 
using in virtuo exposure.
MaTerials anD MeThODs
This study uses an experimental protocol with multiple baselines 
across participants (26–28) in order to test the effectiveness 
of a VR treatment in reducing OCD symptoms. In order to 
demonstrate the effectiveness of the intervention, participants’ 
self-reported symptoms are expected to be “stable” (i.e., not in a 
decreasing trend) at baseline level and decrease when treatment 
was introduced. This experimental design allows for maximiza-
tion of internal validity by introducing treatment at different 
points in time for different individuals and provides experimental 
control over the possible effects of maturation, historical factors, 
and the impact of life events (26–28) by demonstrating that each 
participant improves when treatment is introduced. Participants 
were a priori randomly assigned to a baseline of 3, 4, or 5 weeks 
of “stability” before starting treatment. They were informed of the 
protocol being used and how they had to self-monitor the pres-
ence and intensity of their obsessions and compulsions in a daily 
diary during the duration of the entire study. After the baseline 
period, participants received a manualized cognitive–behavioral 
therapy with VR exposure during a 12-week period [based on Foa 
and Kozak (29)]. Pre- and post-questionnaires were added to the 
protocol in order to obtain additional descriptive data in regard 
to the therapeutic progress of each participant.
Participants
There are no rules specifying the required number of participants 
in multiple baselines protocols, but several case studies have 
been carried out with three or four participants (7, 8, 30, 31). 
Participants were recruited from ads in university and local 
newspapers inviting men and women between the ages of 18 and 
65 years suffering from OCD with a primary subtype of contami-
nation to contact the researchers. All participants were involved 
in a previous validation study of the VR environment [Ref. (25), 
in revision].
The following exclusion criteria were set a priori: (a) a main 
diagnosis other than OCD; (b) a secondary diagnosis of schizo-
phrenia, bipolar disorder, organic brain disorder, intellectual dis-
ability, substance abuse or dependence, or suicidal ideations; (c) 
a primary subtype of OCD other than one related to obsessions 
of contamination and cleaning compulsions; (d) the presence 
of a physical condition contraindicating participation in the 
study (i.e., epilepsy, visual disturbances); (e) a duration of OCD 
of <12 months. Additionally, participants who had been taking 
anxiolytic medication to treat their OCD had to be symptomatic 
and pharmacotherapy must have started at least 6 months prior 
in order to ensure the effectiveness of the dosage. The dosage and 
medication type could not change following entry in the study. 
Finally, participants could not undergo parallel treatments, 
whether pharmacological or psychological, other than the one 
being offered by the study.
Three adults participated in the study (n  =  3). Following 
assessment, they were randomly assigned to a baseline period of 
either 3, 4, or 5 weeks of self-monitoring of target OCD symp toms, 
while symptomatology had to remain stable before  beginning 
treatment. More details about the participants and their treat-
ment are found in the Section “Results.”
Procedure
A telephone interview was conducted before the first appoint-
ment in order to assess whether or not candidate’s symptoms 
were consistent with OCD and whether the current primary 
obsession was contamination. Prospective participants took 
part in a semi-structured diagnostic interview in order to 
establish the presence of a diagnosis of OCD and to assess for 
other potential comorbid disorders as defined by the DSM-
IV-TR (32). The project was approved by the Ethics Research 
Boards of UQO and Ottawa University. Every participant was 
met individually in order to complete the consent form and 
questionnaires. Afterward, therapy took place during a 12-week 
period. CBT included daily self-monitoring of obsessions and 
compulsions for each participant, as well as in virtuo exposure 
during therapy sessions. Two follow-ups were conducted by 
mail in order to determine if therapeutic gains were maintained 
4 and 8 months posttreatment.
Material
Equipment
The experimentation was conducted in a CAVE-like system [i.e., 
similar to Cruz-Neira et al. (33), but not built by the owners of 
the trademark] located in the Cyberpsychology Laboratory of the 
Université du Québec en Outaouais. This immersive system is 
made up of a 10 ft × 10 ft × 10 ft with stereoscopic images projected 
on all surfaces: four walls, floor, and ceiling [see Bouchard et al. 
(34) for a detailed description of the hardware]. The experimenter 
operated the system from outside the closed cube.
Two virtual environments were used, a training environment 
(“neutral”) and an experimental (“contaminated”) environment. 
The training environment consisted of an empty room with three 
windows, a glass door, and a cat resting on a table. The participant 
could hear the calm sound of a breeze and birds singing. The pur-
pose of this environment was to allow participants to familiarize 
themselves with the immersion in the CAVE-like system. The 
training environment was only used once, more specifically at 
the beginning of the fourth session. The therapeutic environment 
depicted a public washroom with various degrees of filthiness (see 
Figure 1) and nothing allowing to eliminate germs (i.e., cleaning 
products, soap, hand sanitizer).
FigUre 1 | screenshots of the virtual environment used for exposure and response prevention in a “contaminated” public toilet.
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instruments
Diagnostic Assessment
The prescreening phone interview was conducted using a 
questionnaire overviewing different OCD symptoms, includ-
ing those related to the contamination subtype. Diagnosis 
was established using the Structured Clinical Interview for 
DSM Disorders [SCID; (35)]. This semi-structured interview 
was conducted by two therapists trained in administering 
the SCID and supervised by a licensed psychologist. The 
establishment of primary and comorbid diagnosis was based 
on clarity and causal sequence of the clinical presentation. If 
there was ambiguity with respect to the primary/secondary 
diagnosis, a consensus was reached between the interviewers 
and supervisor.
Measuring Therapeutic Progress: Self-Monitoring
The primary measure of treatment efficacy was participants’ self-
monitoring of obsessions and compulsions. Participants’ specific 
impulsive thoughts and compulsive behaviors were operational-
ized during the first assessment session. Daily self-monitoring 
based on forms using a similar design (36) were provided to 
participants who had to rate the presence (i.e., the proportion 
of the day during which the intrusive thoughts or impulses were 
present) and intensity (i.e., the strength of intrusive thoughts and 
compulsive behaviors) of their primary obsession and primary 
compulsion. These were recorded on a self-rating form that 
used category partitioning (37) according to the following scale: 
“none,” 0; “minimal,” 1–20; “few,” 21–40; “average,” 41–60; “a lot,” 
61–80, and; “extreme,” 81–100. The literature on OCD suggests 
that percentages should be preferred over hours since, in some 
cases, intrusive thoughts or compulsive behaviors are numer-
ous but short in duration, whereas in others, obsessions are less 
frequent but last longer (38). Participants were informed of the 
importance of completing the self-monitoring every night in 
order to increase therapy’s success.
Symptom Assessment
In order to provide a more detailed measure of frequency, sever-
ity, and diversity of OCD symptoms, therapists administered the 
YBOCS [(39, 40); French translation by Mollard et al. (41)]. The 
YBOCS is a 10-item scale administered by therapist in the form 
of a semi-structured interview to measure the severity of obses-
sions and compulsions. Each item was rated on a five-point scale 
ranging from 0 to 4; 0 reflecting no symptoms and 4 reflecting 
extremely severe symptoms. In order to include participants with 
fear of contamination as their main subtype, participants had 
score higher on this subscale compared with other subtypes.
Measure of Global Functioning
The Trait-Anxiety subscale of the State-Trait-Anxiety Inventory 
[TAI-Y2; (42); validated in French by Gauthier and Bouchard (43)] 
was used to document the general level of anxiety. Daily function-
ing was assessed with the Evaluation of Actual Life Functioning 
[EALF; (44)] measuring seven different life domains, namely, 
(a) occupation or employment, (b) education, (c) social life, (d) 
hobbies, (e) entertainment, (f) holiday, and (g) everyday activities 
(cleaning, shopping, etc.). For each life domain, participant had 
to indicate on a Likert-type scale ranging from 1 (no problem) to 
9 (severe difficulties) the extent to which the OCD symptoms had 
influenced each life domain (1 item per life domain). An average 
was then calculated.
Measures Related to Treatment Using VR
Before the first immersion, participants completed the 
Immersive Tendencies Questionnaire [ITQ; (45)]. This ques-
tionnaire measures participants’ immersive susceptibility in 
a virtual environment by assessing their immersive tendency 
when performing other activities (i.e., reading a book, watch-
ing a movie). The Simulator Sickness Questionnaire [SSQ; (46); 
validated in French by Bouchard et  al. (47)] was used after 
each immersion to measure the extent to which participants 
experienced side effects induced by the immersion in VR (i.e., 
nausea, eye fatigue, dizziness). Following a description of the 
CBT, participants were asked to complete the French adaptation 
by Borkovec and Nau (48) Client Satisfaction Questionnaire 
(CSQ). This measures participant’s perceived credibility in 
regard to proposed treatment using 5 items assessed on a scale 
ranging from 0 to 10.
Measure of Therapeutic Alliance
Therapeutic alliance was measured using the French version 
of the Working Alliance Inventory [WAI; (49, 50)]. The WAI 
is a self-administered questionnaire, containing 36 items that 
measures participant’s perspective on three components of 
the therapeutic alliance between participant and therapist, as 
defined by Bordin (51). It uses Likert-type rating scales, ranging 
from 1 (not true at all) to 7 (completely true) with a maximum 
score of 252.
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Treatment
Cognitive–behavioral therapy unfolded according to a standard-
ized treatment protocol using a guided manual for therapists 
(29). Individual weekly therapy sessions lasted 60 min. Typically, 
each session would begin with a discussion on previous week’s 
homework and self-monitoring of obsessions and compulsions, 
followed by exposure in VR (i.e., touching walls and toilet bowls 
with varying degrees of filthiness) and reviewing the exposure 
session, performing cognitive restructuring of dysfunctional 
thoughts, and discussing upcoming homework assignments 
(52). Homework usually included a review of the didactic mate-
rial viewed in session, the occasional practice of exposure (see 
below), and self-monitoring (29).
The first three sessions aimed at case conceptualization and 
introducing treatment planning. During these sessions, therapist 
gathered information about obsessive fears and rituals and 
developed an exposure hierarchy of anxiety-provoking situations. 
Furthermore, the cognitive–behavioral model of OCD and the 
rationale for exposure and response prevention were discussed. 
Principles of exposure in VR were also briefly discussed. Sessions 
4–11 consisted of exposure and response prevention in VR (in 
virtuo exposure). The first exposure sessions were devoted to 
mild anxiety-provoking situations, which eventually progressed 
to situations causing greater distress. It is important to note that 
participants were systematically asked to refrain from practicing 
exposure outside the therapist’s office during sessions 4–7 (i.e., 
no exposure homework). Homework assignments with in  vivo 
exposure outside the therapist’s office were assigned from ses-
sions 8–11. Contextual information relevant to contamination 
(i.e., “You are in the public toilet of a hospital”) was provided 
verbally before every exposure session. Following in virtuo 
exposure, therapist would draw participant’s attention toward 
their dysfunctional thoughts. Response prevention consisted of 
instructing participants to refrain from any compulsive behavior. 
Session 12 was devoted to relapse prevention. Self-monitoring 
was used between sessions not only to assess outcome but also 
to increase awareness of situations triggering urges to ritualize.
Therapists
Two therapists (Ph.D. candidates) with prior experience in the 
treatment of anxiety disorders with CBT and with previous 
experience in conducting therapy in research protocols admin-
istered all therapy sessions. The therapists had more experience 
with traditional exposure than in virtuo, but had already carried 
out therapy using VR. They received training and hands-on 
experience in treating OCD using the CBT manual. Continuous 
supervision by the senior author, a licensed psychologist with 
18  years of experience with CBT for anxiety disorders and 
9 years of experience in the treatment of anxiety disorders with 
VR, ensured proper monitoring and standardized and uniform 
application of treatment.
Adherence to Treatment Protocol
Assessing how treatment is delivered is important in clinical 
trials (53, 54) and following a clear treatment plan, establishing 
a good therapeutic alliance, explaining treatment rationale, and 
setting explicit goals are expected to increase the likelihood of 
treatment adherence among participants. Each therapy session 
was recorded. Three tapes were randomly selected for each par-
ticipant (25%), one from the initial third of therapy, one from the 
middle, and one from the end of therapy. Two trained independ-
ent experimenters blind to patient’s status in the study listened 
to the tapes and rated them. Recordings were assessed with the 
help of a checklist adapted from the Competency Checklist for 
Cognitive Therapist (55) and the Cognitive Therapy Checklist of 
Therapist Competency (56, 57). Results showed that treatment 
protocol was respected. More specifically, 93.33% of items were 
very well respected by therapists. Only two items were rated as 
fairly respected at times during therapy (proposed exposure 
exercises not allowing avoidance, therapist adequately reviewed 
exercises completed at home).
resUlTs
Overall clinical impressions
Daily data collected from recordings of target OCD symptoms 
(i.e., presence and intensity of obsessions and compulsions) are 
reported in Figures 2–5. The moment at which intervention was 
introduced is indicated with a vertical line.
The first participant is a woman in her mid-20s with a primary 
diagnosis of OCD with contamination subtype, and a second-
ary diagnosis of social anxiety disorder, generalized anxiety 
disorder, and posttraumatic stress disorder. She also displayed 
symptoms from the symmetry and order subtypes, but they 
were deemed of a lesser severity than that of contamination. Her 
Yale–Brown Obsessive–Compulsive Scale [YBOCS; (39, 40)] 
was in the moderate range (see Table  1). She reported having 
never received CBT for OCD before. Her main obsessions were 
related to the contamination of food (cross-contamination) and 
contamination of her hands and objects in her surroundings. The 
case conceptualization explored the specific factors contributing 
to the maintenance of her OCD. They consisted of a difficulty to 
be aware of direct or subtle avoidance behavior and a tendency 
to deny her disorder. The eight VR sessions were focused on her 
daily difficulties (i.e., touching a soap dispenser and the door han-
dle of a public restroom’s toilet stall). Touching the actual floor 
and walls of the CAVE-like system while immersed in the virtual 
environment was encouraged in order to increase her sense of 
presence. Assigned home practice for this participant focused on 
meal preparation as well as exposure to contaminated objects, 
while, at the same time, attempting to reduce or avoid rituals.
The second participant was a woman in her mid-30s with a 
primary diagnosis of OCD with contamination subtype and 
secondary diagnoses of generalized anxiety disorder as well as 
social anxiety disorder. On the YBOCS, Participant 2 scored 
within the range of severe OCD symptoms (see Table 1). She had 
been receiving treatment with a hypnotherapist for about a year. 
Following a discussion with the hypnotherapist, it was clarified 
that no therapeutic efforts had been made to treat her OCD and 
that it was not included in their treatment plan. During treat-
ment, it became clear that her obsessions were mainly triggered 
by factors such as fear of self-contamination or fear of causing 
FigUre 2 | Presence of obsessions on a daily basis for the three participants. The first (solid) vertical line represents when CBT was introduced. The second 
and third (dashed) vertical lines represent when in virtuo exposure was conducted.
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contamination due to “not having washed properly.” Exposure in 
the virtual environment focused on the theme of contamination 
within the context of a filthy public restroom described to the 
patient as “located in a university where students were suffering 
from flu and cold symptoms.” The participant completed eight VR 
exposure sessions, followed by cognitive restructuring on expo-
sure experience (i.e., sticky substances, contaminated air, garbage 
bins). OCDs maintaining factors were also addressed in therapy 
using cognitive restructuring technique. They included low 
self-esteem, depressed mood, social isolation, and a tendency to 
self-criticize. Assigned homework focused on themes addressed 
during therapy sessions that proved to be difficult to recreate using 
VR, such as eating without performing compulsions, preparing a 
meal, and response prevention of compulsions at home, which 
she identified as a “safe zone” and where compulsions were most 
significant.
FigUre 3 | Presence of compulsions on a daily basis for the three participants. The first (solid) vertical line represents when CBT was introduced. The 
second and third (dashed) vertical lines represent when in virtuo exposure was conducted.
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The third participant was a woman in her late 20s with a 
primary diagnosis of OCD with contamination subtype. This 
participant also reported obsessive doubts and compulsions 
of verification, but they appeared to be secondary to the 
fear of contamination. Her YBOCS score placed her in the 
severe range of OCD symptoms (see Table 1). She had never 
received CBT for her OCD. She had also been suffering from 
a depressed mood in recent weeks. It should be noted that 
the last session lasted 120  min as sessions 11 and 12 were 
combined due to time constraints. Her OCD symptoms related 
to the fear of infecting others, especially through a sexually 
transmitted infection (i.e., HIV, herpes). The virtual envi-
ronment depicting filthy public restrooms was presented as 
“being on a university campus and in a hospital.” Throughout 
the eight exposure sessions conducted in VR, tasks involved 
touching unknown sticky surfaces (i.e., floors, walls cabinets, 
toilet bowls), garbage bins, and a used needle. Following 
VR exposure, cognitive restructuring was conducted based 
FigUre 4 | intensity of obsessions on a daily basis for the three participants. The first (solid) vertical line represents when CBT was introduced. The second 
and third (dashed) vertical lines represent when in virtuo exposure was conducted.
8
Laforest et al. Effectiveness of In Virtuo Exposure
Frontiers in Psychiatry | www.frontiersin.org June 2016 | Volume 7 | Article 99
on discussed topics, such as the possibility of contracting a 
sexually transmitted infection. Despite having successfully 
completed VR exposure, Participant 3 showed difficulty with 
respect to homework (i.e., using public restrooms, preparing 
dinner for a friend). Maintaining factors were explored and 
included low self-esteem, difficulty in risk-taking behaviors, 
high personal standards and the presence of an irritable mood 
in regard to her general dissatisfaction with her life (employ-
ment and relationship).
Traditional visual inspection of graphs was performed for 
all three participants (see Figures  2–5). Results suggest that 
interventions had an immediate effect on obsessions and com-
pulsions in the case of Participant 2, as inferred by an apparent 
change in symptom’s level. For Participant 1 and Participant 
3, results are more difficult to interpret on the basis of visual 
inspection, but suggest that the effect takes place progressively 
during the course of the treatment. Toward the end of therapy, 
Participant 1 reported a decrease in OCD symptoms (YBOCS 
FigUre 5 | intensity of compulsions on a daily basis for the three participants. The first (solid) vertical line represents when CBT was introduced. The 
second and third (dashed) vertical lines represent when in virtuo exposure was conducted.
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results in Table 1 are in the range of mild symptoms) and the 
ability to be exposed to anxiety-provoking situations without 
performing rituals. A decrease in OCD symptoms was also 
noted for Participant 2. She reported being able to take risks 
in regard to contamination and to tolerate the associated dis-
comfort. She also mentioned she wanted to keep practicing this 
technique and apply exposure to objects associated with residual 
symptoms of OCD. At posttreatment assessment, this partici-
pants’ YBOCS score was in the range of mild OCD symptoms; 
scores remained stable 4 months after treatment (see Table 1) 
as revealed in follow-up evaluation. As for Participant 3, the 
candidate reported less avoidance, was able to restructure her 
unrealistic thoughts and to challenge her fears, as well as give 
herself better self-appraisal and take greater risks at the end of 
therapy. Her residual symptoms resided mainly in the practice 
of in  vivo behaviors (i.e., using a public restroom); a practice 
that now generates less anxiety compared with the beginning of 
treatment. Her posttreatment score on the YBOCS (see Table 1) 
scaled down to the moderate symptoms range. Scores at follow-
ups remained in the same range.
TaBle 2 | results for time-series analyses performed on the presence 
and the intensity of obsessions and compulsions in the three 
participants.
Variable  
participant
Final arMa 
model
Jung-box intervention  
parameter  
(t-test)
significant change  
occurring  at  
session number
Presence of obsessions
P1 AR-1 19.75 −3.13*** Session 7
P2 AR-1 23.54 −3.42*** Session 1
P3 AR-1 16.63 −4.14*** Session 10
Presence of compulsions
P1 AR-1 25.81 −2.97** Session 6
P2 AR-1 21.16 −5.80*** Session 9
P3 AR-2 9.55 −4.56*** Session 8
intensity of obsessions
P1 AR-1 21.49 −4.86*** Session 9
P2 AR-1 23.15 −2.75*** Session 1
P3 AR-1 20.72 −3.53*** Session 9
intensity of compulsions
P1 AR-2 18.62 −4.28*** Session 8
P2 AR-1 9.50 −7.09*** Session 10
P3 AR-1 9.46 −3.14*** Session 8
AR, autoregression model; MA, moving average model.
**p < 0.01, ***p < 0.001. 
TaBle 1 | results for measures of anxiety and daily functioning completed pre- and posttreatments as well as at the fourth and eighth month 
follow-ups.
Participant 1 Participant 2 Participant 3
Measures Pre Post Follow-up 
4 months
Follow-up 
8 months
Pre Post Follow-up 
4 months
Follow-up 
8 months
Pre Post Follow-up 
4 months
Follow-up 
8 months
YBOCS 22 14 16 21 31 14 11 11 30 21 23 27
TAI-Y2 32 31 29 28 61 60 46 46 56 59 54 64
EALF 3.5 2.3 2.3 2.3 5.3 3.0 1.3 1.5 7.8 5.5 7.5 8.3
YBOCS, Yale–Brown Obsessive–Compulsive Scale; TAI-Y2, Trait-Anxiety Inventory (Form Y2 of the STAI); EALF, evaluation of actual life functioning.
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Time-series analyses
To compensate for the subjective nature of visual examination 
comparing symptom’s during baseline and following the intro-
duction of the intervention, researchers can use more powerful, 
rigorous, and reliable statistical methods that allow description 
of events based on mathematical models in order to assess 
the impact of an intervention (27, 28, 30, 58–62). Time-series 
analyses [or ARMA (63, 64)] were used as the primary tool to test 
whether the impact of the CBT using VR was statistically signifi-
cant. Time-series analyses are statistical procedure that tests the 
influence of an intervention on series of observations collected 
at regular intervals, while controlling for autocorrelation in the 
data. Such analyses allow to test changes in the level and slope 
of the series (65) after the introduction of the intervention (i.e., 
compared with baseline self-monitoring of presence and intensity 
of obsessions and compulsions). The final ARMA intervention 
models are reported in Table 2.
The ARMA time-series analyses (63, 64) confirmed our 
hypotheses that the impact of the intervention is statistically 
significant for all participants. This effect was manifested clearly 
immediately after the introduction of treatment in the case of 
presence and intensity of obsessions for Participant 2, and after 
a few sessions of exposure (between sessions 4 and 11) in regard 
to other variables and other participants. The magnitude of the 
impact of the intervention remains greater for Participant 1 and 
2 than for Participant 3.
self-reported Measures at Pre- and 
Posttreatment and Follow-Ups
Table 1 summarizes results in terms of anxiety and general daily 
functioning of the three participants. These data were not used 
to demonstrate the effectiveness of the treatment, but rather as 
descriptive clinical add-on to the ARMA analyses. With results 
obtained on the YBOCS, it is possible to observe that obsessive 
and compulsive symptoms showed clinical improvement during 
the course of treatment for all three participants. Results vary 
among participants at follow-ups, with Participants 2 showing 
lasting improvements at follow-ups and Participant 1 showing 
relapse on the Y-BOCS at the 8-month follow-up. Participant 3 
did not show much improvement at the last follow-up.
Treatment and Vr experience-related 
Questionnaires
Participants considered the combined VR with CBT treatment as 
highly credible (CSQ total score: median = 49.67 on a maximum 
of 50). The therapeutic alliance established between participants 
and therapists was strong (WAI total score: median =  237 on 
a maximum of 252). Participants’ reported a high propensity 
to be immersed in a virtual environment (ITQ total score: 
median = 81.67 on a maximum of 126). In terms of unwanted 
negative side effects experienced after immersion in VR, partici-
pants reported low levels of unwanted negative side effects, with 
slight variations from one session to the next.
DiscUssiOn
The objective of this study was to examine the potential efficacy of 
using VR to conduct exposure with people suffering from OCD 
with contamination fears. To this end, the presence and intensity 
of obsessions and compulsions were documented in a single-case 
study where patients are used as their own control with treatment 
introduced at different moments in order to evaluate if its impact 
follows the introduction of the intervention. After analysis, results 
provide preliminary evidence for the effectiveness and usefulness 
of VR in the treatment of OCD.
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Based on visual inspection of data and time-series analyses, it 
is possible to believe the intervention significantly improved OCD 
symptoms for each participant. The intervention’s effect is clearer 
in regard to obsessions reported by Participant 2, but this effect 
seems to appear later in exposure sessions for the other two par-
ticipants, both for obsessions and compulsions. It is interesting to 
note that the “contaminated” virtual environment was more akin 
to Participant 2’s specific obsessions and compulsions (i.e., fear of 
contact with germs that could then contaminate someone else), 
compared with Participant 1 (i.e., contamination of food) and 
Participant 3 (i.e., contracting a sexually transmitted infection).
At the time of assessment, YBOCS score for all participants was 
contained in the moderate to severe range. Following treatment, 
Participants 1 and 2 reported a score in the mild range of the 
scale, thus indicating a clear reduction of obsessive–compulsive 
symptoms. These gains were maintained up to 4 months (follow-
up) after the end of treatment. As for Participant 3, her YBOCS 
score was reduced from the severe to moderate range following 
treatment and was maintained until 4-month follow-up. For all 
three participants, there was a slight loss in therapeutic gains as 
indicated by results obtained on the YBOCS at 8-month follow-up. 
As with OCD symptoms, trait anxiety improved for Participant 2, 
but this improvement was less pronounced for Participant 1 and 
would have increased at 8-month follow-up for Participant 3. 
A similar pattern is observed with participants’ daily functioning.
Given these results, we are questioning the duration of the 
treatment used in this pilot study, as well as whether booster ses-
sions would have been useful in the maintenance of therapeutic 
gains. It is possible that 12 sessions of CBT, including 8 sessions of 
in virtuo exposure, are insufficient for the treatment of a chronic 
and complex disorder such as OCD. Indeed, length of CBT can 
vary between 5 and 22 sessions of CBT (66). In addition, we 
cannot deny the impact of each participant’s individual factors 
on treatment. To this effect, a study led by Keijsers et  al. (67) 
highlighted the detrimental impact of variables such as initial 
severity of OCD, comorbid depression, chronicity of OCD as well 
as client’s motivation on the prognosis of patients suffering from 
OCD. In the case of our study, Participant 3 had been suffering 
from severe OCD for 5 years, showed depressed mood and had 
difficulty completing exposure outside of the therapist’s office. 
This reluctance appeared to be caused by her depressed mood, 
which negatively influenced her motivation, and fear of exposure 
homework. Fear of exposure was present but easier to manage 
in VR. Following these considerations, a treatment of longer 
duration including more VR exposure sessions would have pos-
sibly promoted better outcome and encouraged generalization of 
treatment gains.
In regard to patient’s perception of the treatment, participants 
positively assessed CBT with in virtuo exposure. All three par-
ticipants exhibited high susceptibility to immersion in a virtual 
environment and felt little unwanted negative side effects during 
exposure. A strong therapeutic alliance was created by therapists. 
Following these considerations, our results support the potential 
of VR in the treatment of OCD.
This pilot study is not without limitations. Since the study is 
based on an individual protocol with three participants, gener-
alization of the results is limited. In addition, our sample was 
composed entirely of women. In this same perspective, differences 
in symptom’s severity may also blur the results. The duration of 
the treatment may need to be adjusted and adapted to other CBT 
protocols [e.g., Ref. (1)]. Given the promising results of this study, 
it would be important to reproduce the methodology with a larger 
and more diverse sample (gender, age, and ethnicity) as part of a 
controlled study protocol with random assignment by comparing 
in virtuo treatment with traditional in vivo treatment. It would also 
be interesting to explore other subtypes of OCD (i.e., symmetry, 
moral and religion, verification) as well as its impact on chronicity 
and severity of symptoms. In this regards, VR environments are 
being developed for other subtypes of OCD [e.g., Ref. (68)].
Participants in this study all reported anecdotes about how 
they were able to expose themselves to some particular fears in 
VR with moderate to severe anxiety (i.e., touching the floor of a 
public restroom), but felt they would not have been able expose 
themselves to such stimuli in vivo at that moment in their treat-
ment. It is possible that VR allows participants to practice expo-
sure technique during session with the assistance of a therapist 
and help them be better able to implement exposure in vivo or 
as homework.
In conclusion, we wish to emphasize that VR has proven itself 
in the field of psychological research, but appears in its infancy 
in regard to its use in clinical practice. Recently, some researchers 
have focused their attention on the implementation mechanisms 
of this new technology to understand the reasons for its under-
utilization amongst clinicians. A survey of 262 therapists by 
Schwartzman et al. (69) found that clinicians are reluctant to use 
VR due to beliefs that using such technology requires training, 
equipment, and high financial costs. In addition, most therapists 
reported not knowing the benefits and applications of VR. 
Another study led by Bertrand and Bouchard (70) demonstrated 
that the intention to use VR is mostly predicted by the therapists’ 
perception of its usefulness as a part of treatment. To ensure wider 
and more efficient use of this technology in clinical practice, the 
dissemination of knowledge about the various applications and 
the numerous benefits of VR is essential to correct erroneous 
beliefs held by clinicians. Schwartzman and colleagues discussed 
the importance of informing clinicians through conferences and 
scientific journals, and especially to correct myths about costs. 
Dissemination of information related to VR and is applications 
may encourage greater use in clinical settings and consequently 
improve access of VR for patients.
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